chr1-151103574-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144618.3(GABPB2):c.635C>T(p.Ala212Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144618.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABPB2 | ENST00000368918.8 | c.635C>T | p.Ala212Val | missense_variant | 6/9 | 1 | NM_144618.3 | ENSP00000357914.3 | ||
GABPB2 | ENST00000467551.1 | n.293-3463C>T | intron_variant | 1 | ||||||
GABPB2 | ENST00000368916.1 | c.623-3463C>T | intron_variant | 5 | ENSP00000357912.1 | |||||
GABPB2 | ENST00000489549.5 | n.673C>T | non_coding_transcript_exon_variant | 6/7 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152136Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251298Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135822
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1460954Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726832
GnomAD4 genome AF: 0.000197 AC: 30AN: 152254Hom.: 0 Cov.: 31 AF XY: 0.000107 AC XY: 8AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.635C>T (p.A212V) alteration is located in exon 6 (coding exon 5) of the GABPB2 gene. This alteration results from a C to T substitution at nucleotide position 635, causing the alanine (A) at amino acid position 212 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at